Transforming Life Sciences - From molecule to market
Connecting research, development, and manufacturing to accelerate the future of life sciences.
The race to deliver innovative therapies is accelerating. With its strategic vision and digital transformation framework „From Molecule to Market“, Siemens connects research, development and manufacturing into one seamless digital journey. Powered by Siemens Xcelerator, Dotmatics and technologies like AI and digital twins, this approach simplifies complexity, speeds up processes and ensures consistent quality.
From molecule to market
On October 1, 2026, Siemens City Vienna becomes again the place to be for the life science community. Join us as we explore how ideas evolve into impact—across research, development and market-ready innovation.
A special highlight of the event will be the keynote presentations by Prof. Alois Jungbauer from BOKU University and Accenture, highlighting key trends in pharma and biotech and exploring how the industry is evolving from lab to line towards connected, data-driven operations.
The program will also feature contributions from Takeda, Fresenius and VTU - additional partners and end customers to be announced.
Location: Siemens City Vienna, Siemensstraße 90, 1210 Vienna
Date: October 1, 2026
Get together & Welcome coffee: 1:30 pm
Presentations / Keynotes in plenum: 2:00 pm – 6:00 pm
Lab tour & Networking dinner: 6:30 pm onwards
The detailed program will be available in the next weeks.
Last year’s Pharma Connect event, From Code to Cure, brought together industry experts in an international setting, featuring innovative presentations on digital transformation, smart manufacturing, and sustainability in pharma. The program concluded with engaging discussions and valuable networking opportunities.
Building on this momentum, the 2026 edition will continue to expand the conversation – bringing fresh perspectives and new ideas to stage.
